RecruitingNot applicableNCT07216209
Official study title

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

Study summary

There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-operative outcomes and that strenuous exercise will alter the TME and genetic make-up of the tumor, improving the tumor immune response. Investigators aim to identify the peri-operative and clinical outcomes that differ based on pre-operative VO2max, HRV and resting heart rate following resection of early-stage lung cancer. The physiologic states that are individual and measurable with wearable devices include but are not limited to VO2max, heart rate variability (HRV), and average resting heart rate. Investgators hypothesize that a patient's pre-operative physiologic function with higher VO2max, HRV and lower resting heart rate will be associated with improved peri-operative and post-operative outcomes. Second, investigators will compare alterations in TME based on targeted pre-operative exercise (60-80% of their VO2 max for 75min/week x2 weeks) compared to normal activity adults following resection of early-stage lung cancer. Investigators hypothesize that strenuous exercise in the pre-operative period will impact the TME by increasing levels of cytokines.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedEXERCISE TRAINING WITH OR WITHOUT MEDICATION

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC) · Early-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 21, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Arizona

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
University of Arizona
Interventions being studied
Behavioral: EXERCISE TRAINING WITH OR WITHOUT MEDICATION
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • lung cancer
  • low risk for submaximal exercise testing in accordance with the risk stratification guidelines published by the American Heart Association and the American College of Sports Medicine (AHA/ACSM criteria).
Reasons someone may not be able to joinExclusion criteria
  • younger than 18 years of age
  • select a condition on the ACSM-AHA pre-exercise screening questionnaire indicating that physician approval is required prior to exercise
  • body mass index of \>30 kg/m2
  • waist girth of \>102cm for men and \>88cm for women
  • have chronic/debilitating arthritis
  • have been bedridden in the past three months
  • have common illness (i.e. colds) within the past 6-weeks
  • HIV
  • hepatitis
  • history of stroke
  • major affective disorder
  • autoimmune disease
  • pregnancy or are breast-feeding
  • history of severe anaphylactic reaction to an allergen
  • present with more than one of the following CVD risk factors: family history of myocardial infarction, coronary revascularization, or sudden death before 55 years of age in father or other male first-degree relative or before 65 years of age in mother or other female first-degree relative

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Arizona Cancer CenterTucson, Arizona

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 21, 2026. Always confirm current availability with the study team.

View original record ↗